These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 34816262)
1. LinearTurboFold: Linear-Time Global Prediction of Conserved Structures for RNA Homologs with Applications to SARS-CoV-2. Li S; Zhang H; Zhang L; Liu K; Liu B; Mathews DH; Huang L bioRxiv; 2021 Nov; ():. PubMed ID: 34816262 [TBL] [Abstract][Full Text] [Related]
2. LinearTurboFold: Linear-time global prediction of conserved structures for RNA homologs with applications to SARS-CoV-2. Li S; Zhang H; Zhang L; Liu K; Liu B; Mathews DH; Huang L Proc Natl Acad Sci U S A; 2021 Dec; 118(52):. PubMed ID: 34887342 [TBL] [Abstract][Full Text] [Related]
3. LazySampling and LinearSampling: fast stochastic sampling of RNA secondary structure with applications to SARS-CoV-2. Zhang H; Li S; Zhang L; Mathews DH; Huang L Nucleic Acids Res; 2023 Jan; 51(2):e7. PubMed ID: 36401871 [TBL] [Abstract][Full Text] [Related]
4. LazySampling and LinearSampling: Fast Stochastic Sampling of RNA Secondary Structure with Applications to SARS-CoV-2. Zhang H; Zhang L; Li S; Mathews DH; Huang L bioRxiv; 2021 Nov; ():. PubMed ID: 33398265 [TBL] [Abstract][Full Text] [Related]
5. LinearAlifold: Linear-time consensus structure prediction for RNA alignments. Malik A; Zhang L; Gautam M; Dai N; Li S; Zhang H; Mathews DH; Huang L J Mol Biol; 2024 Sep; 436(17):168694. PubMed ID: 38971557 [TBL] [Abstract][Full Text] [Related]
6. The global and local distribution of RNA structure throughout the SARS-CoV-2 genome. Tavares RCA; Mahadeshwar G; Wan H; Huston NC; Pyle AM J Virol; 2021 Mar; 95(5):. PubMed ID: 33268519 [TBL] [Abstract][Full Text] [Related]
7. LinearAlifold: Linear-Time Consensus Structure Prediction for RNA Alignments. Malik A; Zhang L; Gautam M; Dai N; Li S; Zhang H; Mathews DH; Huang L ArXiv; 2024 Jul; ():. PubMed ID: 35795813 [TBL] [Abstract][Full Text] [Related]
8. Taxonium, a web-based tool for exploring large phylogenetic trees. Sanderson T Elife; 2022 Nov; 11():. PubMed ID: 36377483 [TBL] [Abstract][Full Text] [Related]
9. Identification of conserved regions from 230,163 SARS-CoV-2 genomes and their use in diagnostic PCR primer design. Jeong H; Lee S; Ko J; Ko M; Seo HW Genes Genomics; 2022 Aug; 44(8):899-912. PubMed ID: 35653026 [TBL] [Abstract][Full Text] [Related]
10. A one-step platform for screening high-efficient and minimal off-target CRISPR/Cas13 crRNAs to eradicate SARS-CoV-2 virus for treatment of COVID-19 patients. Li PY; Li SQ; Gao SG; Dong DY Med Hypotheses; 2022 Feb; 159():110754. PubMed ID: 35002020 [TBL] [Abstract][Full Text] [Related]
11. In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack. Hussein M; Andrade Dos Ramos Z; Berkhout B; Herrera-Carrillo E Viruses; 2022 Feb; 14(2):. PubMed ID: 35215977 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus. Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668 [TBL] [Abstract][Full Text] [Related]
14. RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses. Rangan R; Zheludev IN; Das R bioRxiv; 2020 Apr; ():. PubMed ID: 32511306 [TBL] [Abstract][Full Text] [Related]
15. FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip. Kumar M; Gulati S; Ansari AH; Phutela R; Acharya S; Azhar M; Murthy J; Kathpalia P; Kanakan A; Maurya R; Vasudevan JS; S A; Pandey R; Maiti S; Chakraborty D Elife; 2021 Jun; 10():. PubMed ID: 34106048 [TBL] [Abstract][Full Text] [Related]
16. Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline. Kuchinski KS; Jassem AN; Prystajecky NA J Clin Virol; 2020 Oct; 131():104581. PubMed ID: 32889496 [TBL] [Abstract][Full Text] [Related]
17. Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeutics. Babalola BA; Akinsuyi OS; Folajimi EO; Olujimi F; Otunba AA; Chikere B; Adewumagun IA; Adetobi TE Biomed Pharmacother; 2023 Sep; 165():115099. PubMed ID: 37406505 [TBL] [Abstract][Full Text] [Related]
18. A Novel Miniature CRISPR-Cas13 System for SARS-CoV-2 Diagnostics. Mahas A; Wang Q; Marsic T; Mahfouz MM ACS Synth Biol; 2021 Oct; 10(10):2541-2551. PubMed ID: 34546709 [TBL] [Abstract][Full Text] [Related]
19. A novel method for conserved sequence extraction with prospective mutation prediction for SARS-CoV-2 PCR primer design. Portakal SH; Kanat B; Sayan M; Berber B; Doluca O J Virol Methods; 2021 Jul; 293():114146. PubMed ID: 33812944 [TBL] [Abstract][Full Text] [Related]
20. Current Strategies of Antiviral Drug Discovery for COVID-19. Mei M; Tan X Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]